A multiplex Mtb-specific FluoroSpot assay measuring IFNγ, IL-2, and TNF-secreting cells can improve accuracy and differentiation across the tuberculosis spectrum
Journal of Clinical Microbiology · 2025
DOI: 10.1128/jcm.00894-25 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Elin Folkesson und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Tuberculosis, Interferon-gamma, Interleukin-2, Mycobacterium tuberculosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Svenska Sällskapet för Medicinsk Forskning, Svenska Läkaresällskapet, Stiftelsen Läkare mot AIDS Forskningsfond.
Abstract (Originalsprache)
Tuberculosis (TB) remains a major global health challenge, with current diagnostic tools unable to reliably distinguish between individuals at different stages of the TB spectrum of infection (TBI) and disease (TBD). Interferon-gamma release assays (IGRAs), while commonly used, are limited by their reliance on a single cytokine and inability to differentiate disease states. In this study, we evaluated a multiplex FluoroSpot assay that simultaneously detects interferon gamma (IFNγ), interleukin (IL)2, and tumor necrosis factor (TNF)-secretion in response to Mycobacterium tuberculosis ( Mtb ) antigens ESAT-6, CFP-10, and EspC. PBMCs from individuals with TBD ( n = 24), TBI ( n = 64), and IGRA-negative controls ( n = 26) were analyzed. The assay demonstrated high sensitivity and specificity, particularly through the detection of triple cytokine-secreting T cells (IFNγ/IL-2/TNF), minimizing false-positive rates. Moreover, distinct cytokine secretion patterns were associated with different stages of infection. Individuals with TBD had more IFNγ/TNF-producing cells, while those with TBI had more cells producing IFNγ/IL-2 or IL-2/TNF. Separating individuals with TBI based on time since likely Mtb exposure revealed that more recent infection was associated with reduced IFNγ responses and a higher proportion of IL-2/TNF-secreting cells. The use of spot volume analysis provided semi-quantitative insights into cytokine production. These findings suggest that multiplex cytokine profiling can improve TB diagnostics and offer a deeper understanding of host immune responses across the TB spectrum. Including non-IFNγ responses may be particularly valuable in identifying individuals at higher risk of disease progression, such as recently infected individuals, and in populations where current diagnostics underperform. IMPORTANCE Accurate diagnosis of Mycobacterium tuberculosis ( Mtb ) infection remains a cornerstone in tuberculosis (TB) control. Current interferon-gamma release assays (IGRAs) lack the ability to distinguish between individuals at different stages of the TB infection spectrum, limiting their utility. This study evaluates a multiplex FluoroSpot assay that simultaneously detects interferon gamma (IFNγ), interleukin 2, and tumor necrosis factor secretion in response to Mtb -specific antigens ESAT-6, CFP-10, and EspC. The assay demonstrated improved performance compared to standard IGRA methods, particularly through the identification of triple cytokine-secreting T cells. Importantly, it revealed distinct cytokine profiles associated with different stages of TB infection, offering potential for improved risk stratification and infection monitoring. These findings support the FluoroSpot assay as a promising tool for enhancing TB diagnostics and understanding host immune responses. Its application could be especially valuable in contact tracing, where Mtb -specific T-cell responses may not yet produce detectable amounts of IFNγ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
- Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
- Therapeutic Immune Design, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
- ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
ORCID-Profile: Elin Folkesson, Linn Kleberg, Carolina Sousa Silva, Maia S Gower, Hans Grönlund, Bartek Makower, Gunilla Källenius, Judith Bruchfeld, Christopher Sundling
Förderung
- Svenska Sällskapet för Medicinsk Forskning
- Svenska Läkaresällskapet
- Stiftelsen Läkare mot AIDS Forskningsfond
- Hjärt-Lungfonden
- Swedish Research Council
Zitieren
APA
Folkesson, E., Foroogh, F., Kleberg, L., Kjellgren, V., Jakobsson, M., Grunewald, L., Hellberg, J., Ryberg, J., Maher, Z., Silva, C. S., Gower, M. S., Grönlund, H., Correia-Neves, M., Makower, B., Källenius, G., Bruchfeld, J., & Sundling, C. (2025). A multiplex Mtb-specific FluoroSpot assay measuring IFNγ, IL-2, and TNF-secreting cells can improve accuracy and differentiation across the tuberculosis spectrum. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00894-25
Vancouver
Folkesson E, Foroogh F, Kleberg L, Kjellgren V, Jakobsson M, Grunewald L, et al. A multiplex Mtb-specific FluoroSpot assay measuring IFNγ, IL-2, and TNF-secreting cells can improve accuracy and differentiation across the tuberculosis spectrum. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.00894-25
BibTeX
@article{Folkesson2025,
author = {Folkesson, Elin and Foroogh, Fariba and Kleberg, Linn and Kjellgren, Vera and Jakobsson, Mathilda and Grunewald, Lisann and Hellberg, Jens and Ryberg, Jennifer and Maher, Zahra and Silva, Carolina Sousa and Gower, Maia S and Grönlund, Hans and Correia-Neves, Margarida and Makower, Bartek and Källenius, Gunilla and Bruchfeld, Judith and Sundling, Christopher},
title = {A multiplex Mtb-specific FluoroSpot assay measuring IFNγ, IL-2, and TNF-secreting cells can improve accuracy and differentiation across the tuberculosis spectrum},
journal = {Journal of Clinical Microbiology},
year = {2025},
doi = {10.1128/jcm.00894-25}
}
EUVIMED